These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 7758881
1. Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM. Dinneen S, Alzaid A, Turk D, Rizza R. Diabetologia; 1995 Mar; 38(3):337-43. PubMed ID: 7758881 [Abstract] [Full Text] [Related]
13. Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, Rizza RA. Diabetologia; 2001 Jun; 44(6):729-37. PubMed ID: 11440366 [Abstract] [Full Text] [Related]
14. The effects of hyperglycaemia on isotopic measurement of glucose utilisation using [2(3)H], [3(3)H] and [6(14)C] glucose in patients with type 1 (insulin-dependent) diabetes mellitus. Bell PM, Firth RG, Rizza RA. Diabetologia; 1987 Jun; 30(6):365-71. PubMed ID: 2890547 [Abstract] [Full Text] [Related]
15. Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance. Del Prato S, Matsuda M, Simonson DC, Groop LC, Sheehan P, Leonetti F, Bonadonna RC, DeFronzo RA. Diabetologia; 1997 Jun; 40(6):687-97. PubMed ID: 9222649 [Abstract] [Full Text] [Related]
16. Assessment of insulin action in NIDDM in the presence of dynamic changes in insulin and glucose concentration. Katz H, Homan M, Jensen M, Caumo A, Cobelli C, Rizza R. Diabetes; 1994 Feb; 43(2):289-96. PubMed ID: 8288053 [Abstract] [Full Text] [Related]
17. Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk FW, Holst JJ, Rizza RA. Diabetes; 2001 Mar; 50(3):565-72. PubMed ID: 11246876 [Abstract] [Full Text] [Related]
18. Peripheral and hepatic insulin sensitivity in subjects with impaired glucose tolerance. Berrish TS, Hetherington CS, Alberti KG, Walker M. Diabetologia; 1995 Jun; 38(6):699-704. PubMed ID: 7672492 [Abstract] [Full Text] [Related]
19. Reduced postprandial hyperglycemia after subcutaneous injection of a somatostatin-analogue (SMS 201-995) in insulin-dependent diabetes mellitus. Spinas GA, Bock A, Keller U. Diabetes Care; 1985 Jun; 8(5):429-35. PubMed ID: 2865093 [Abstract] [Full Text] [Related]
20. Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy. Pehling G, Tessari P, Gerich JE, Haymond MW, Service FJ, Rizza RA. J Clin Invest; 1984 Sep; 74(3):985-91. PubMed ID: 6381541 [Abstract] [Full Text] [Related] Page: [Next] [New Search]